27334470|t|Genomic analysis of nontypeable pneumococci causing invasive pneumococcal disease in South Africa, 2003-2013
27334470|a|The capsular polysaccharide is the principal virulence factor of Streptococcus pneumoniae and a target for current pneumococcal vaccines. However, some pathogenic pneumococci are serologically nontypeable [nontypeable pneumococci (NTPn)]. Due to their relative rarity, NTPn are poorly characterized, and, as such, limited data exist which describe these organisms. We aimed to describe disease and genotypically characterize NTPn causing invasive pneumococcal disease in South Africa. Isolates were detected through national, laboratory - based surveillance for invasive pneumococcal disease in South Africa and characterized by whole genome analysis. We predicted ancestral serotypes (serotypes from which NTPn may have originated) for Group I NTPn using multilocus sequence typing and capsular region sequence analyses. Antimicrobial resistance patterns and mutations potentially causing nontypeability were identified. From 2003-2013, 39 (0.1 %, 39/32,824) NTPn were reported. Twenty-two (56 %) had partial capsular genes (Group I) and 17 (44 %) had complete capsular deletion of which 15 had replacement by other genes (Group II). Seventy-nine percent (31/39) of our NTPn isolates were derived from encapsulated S. pneumoniae. Ancestral serotypes 1 (27 %, 6/22) and 8 (14 %, 3/22) were most prevalent, and 59 % (13/22) of ancestral serotypes were serotypes included in the 13-valent pneumococcal conjugate vaccine. We identified a variety of mutations within the capsular region of Group I NTPn, some of which may be responsible for the nontypeable phenotype. Nonsusceptibility to tetracycline and erythromycin was higher in NTPn than encapsulated S. pneumoniae. NTPn are currently a rare cause of invasive pneumococcal disease in South Africa and represent a genetically diverse collection of isolates.
27334470	0	16	Genomic analysis	T059	C3854164
27334470	20	43	nontypeable pneumococci	T007	C0038410
27334470	52	81	invasive pneumococcal disease	T047	C1320214
27334470	85	97	South Africa	T083	C0037712
27334470	113	136	capsular polysaccharide	T109	C1979807
27334470	154	170	virulence factor	T109,T123,T131	C1136170
27334470	174	198	Streptococcus pneumoniae	T007	C0038410
27334470	205	211	target	T169	C1521840
27334470	224	245	pneumococcal vaccines	T121,T129	C0358314
27334470	261	271	pathogenic	T033	C3816499
27334470	272	283	pneumococci	T007	C0038410
27334470	288	313	serologically nontypeable	T170	C0449943
27334470	315	338	nontypeable pneumococci	T007	C0038410
27334470	340	344	NTPn	T007	C0038410
27334470	370	376	rarity	T080	C0522498
27334470	378	382	NTPn	T007	C0038410
27334470	394	407	characterized	T052	C1880022
27334470	431	435	data	T078	C1511726
27334470	463	472	organisms	T001	C0029235
27334470	495	502	disease	T047	C0012634
27334470	507	520	genotypically	T032	C0017431
27334470	521	533	characterize	T052	C1880022
27334470	534	538	NTPn	T007	C0038410
27334470	547	576	invasive pneumococcal disease	T047	C1320214
27334470	580	592	South Africa	T083	C0037712
27334470	594	602	Isolates	T123	C1764827
27334470	635	645	laboratory	T073,T093	C0022877
27334470	648	653	based	T078	C1705938
27334470	654	666	surveillance	T169	C0220920
27334470	671	700	invasive pneumococcal disease	T047	C1320214
27334470	704	716	South Africa	T083	C0037712
27334470	721	734	characterized	T052	C1880022
27334470	744	759	genome analysis	T059	C3854164
27334470	774	783	ancestral	T169	C0439660
27334470	784	793	serotypes	T170	C0449943
27334470	795	804	serotypes	T170	C0449943
27334470	816	820	NTPn	T007	C0038410
27334470	846	853	Group I	T078	C0441833
27334470	854	858	NTPn	T007	C0038410
27334470	865	891	multilocus sequence typing	T062	C2936544
27334470	896	911	capsular region	T082	C1254362
27334470	912	929	sequence analyses	T059,T063	C0162801
27334470	931	955	Antimicrobial resistance	T201	C1456627
27334470	956	964	patterns	T082	C0449774
27334470	969	978	mutations	T045	C0026882
27334470	979	990	potentially	T080	C3245505
27334470	999	1013	nontypeability	T170	C0449943
27334470	1019	1029	identified	T080	C0205396
27334470	1069	1073	NTPn	T007	C0038410
27334470	1089	1099	Twenty-two	T081	C4284772
27334470	1111	1118	partial	T081	C0728938
27334470	1119	1133	capsular genes	T028	C0017337
27334470	1135	1142	Group I	T078	C0441833
27334470	1162	1170	complete	T080	C0205197
27334470	1171	1188	capsular deletion	T045	C0017260
27334470	1205	1216	replacement	T169	C0559956
27334470	1226	1231	genes	T028	C0017337
27334470	1233	1241	Group II	T078	C0441833
27334470	1244	1256	Seventy-nine	T081	C3828184
27334470	1257	1264	percent	T081	C0439165
27334470	1280	1284	NTPn	T007	C0038410
27334470	1285	1293	isolates	T123	C1764827
27334470	1312	1324	encapsulated	T080	C0205223
27334470	1325	1338	S. pneumoniae	T007	C0038410
27334470	1350	1359	serotypes	T170	C0449943
27334470	1435	1444	ancestral	T169	C0439660
27334470	1445	1454	serotypes	T170	C0449943
27334470	1460	1469	serotypes	T170	C0449943
27334470	1486	1526	13-valent pneumococcal conjugate vaccine	T121,T129	C3152625
27334470	1555	1564	mutations	T045	C0026882
27334470	1576	1591	capsular region	T082	C1254362
27334470	1595	1602	Group I	T078	C0441833
27334470	1603	1607	NTPn	T007	C0038410
27334470	1650	1661	nontypeable	T170	C0449943
27334470	1662	1671	phenotype	T032	C0031437
27334470	1673	1690	Nonsusceptibility	T034	C2827756
27334470	1694	1706	tetracycline	T109,T195	C0039644
27334470	1711	1723	erythromycin	T109,T195	C0014806
27334470	1738	1742	NTPn	T007	C0038410
27334470	1748	1760	encapsulated	T080	C0205223
27334470	1761	1774	S. pneumoniae	T007	C0038410
27334470	1776	1780	NTPn	T007	C0038410
27334470	1811	1840	invasive pneumococcal disease	T047	C1320214
27334470	1844	1856	South Africa	T083	C0037712